PHARMASGP HOLDING SE O.N.
PHARMASGP HOLDING SE O.N./ DE000A2P4LJ5 /
PSG
|
2024-11-13 9:26:11 PM
|
Chg.
+1.00
|
Volume |
Bid9:26:14 PM |
Ask9:26:14 PM |
Market Capitalization |
Dividend Y. |
P/E Ratio |
|
24.20EUR
|
+4.31%
|
70
Turnover: 1,698 |
24.00Bid Size: 50 |
24.60Ask Size: 50 |
292.62 mill.EUR |
5.57% |
17.81 |
Fundamentals
| |
FY 2023 |
Growth (1Y) |
| Per Share |
|
| Earnings per Share: |
1.37 EUR |
37.00% |
| EPS Diluted: |
- EUR |
37.00% |
| Revenues per Share: |
8.43 EUR |
-99.88% |
| Book Value per Share: |
3.31 EUR |
27.92% |
| Cash Flow per Share: |
2.22 EUR |
7.86% |
| Dividend per Share: |
1.36 EUR |
177.55% |
| Total |
in mill. |
|
| Revenues: |
101.10 EUR |
-99.88% |
| Net Income: |
16.40 EUR |
37.17% |
| Operating Cash Flow: |
26.64 EUR |
- |
| Cash and Cash Equivalents: |
40.77 EUR |
- |
Valuation Ratios
| |
Current |
Latest FY* |
| P/E Ratio: |
17.81 |
15.91 |
| P/S Ratio: |
2.89 |
2.59 |
| P/BV ratio: |
7.36 |
6.58 |
| P/CF Ratio: |
10.98 |
9.81 |
| PEG: |
0.48 |
0.43 |
| Earnings Yield: |
5.61% |
6.28% |
| Dividend Yield: |
5.57% |
6.24% |
| Market Capitalization |
|
| Market Capitalization: |
292.62 mill. EUR |
261.44 mill. EUR |
| Free Float Market Cap.: |
- EUR |
- EUR |
| Market Cap. / Employee: |
3.29 mill. EUR |
2.94 mill. EUR |
| Shares Outstanding: |
11.99 mill. |
|
Profitability
| Gross Profit Margin: |
- |
| EBIT Margin: |
24.37% |
| Net Profit Margin: |
16.22% |
| Return on Equity: |
41.25% |
| Return on Assets: |
12.49% |
Financial Strength
| Liquidity I / Cash Ratio: |
165.76% |
| Liquidity II / Quick Ratio: |
203.12% |
| Liquidity III / Current Ratio: |
255.42% |
| Debt / Equity Ratio: |
230.28% |
| Dynam. Debt / Equity Ratio: |
343.65% |
Efficiency
| Employees: |
89 |
| Personal Expenses / Employee: |
- EUR |
| Revenues / Employee: |
1,135,943.82 EUR |
| Net Income / Employee: |
184,235.96 EUR |
| Total Assets / Employee: |
1,475,269.66 EUR |
| * Fiscal Year End: |
2023-12-31 |
| Accounting Standard: |
IFRS |
